Tranche Update on J Frontier Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2021.
December 15, 2021 at 08:00 pm EST
Share
From December 15, 2021 to December 16, 2021, the company has repurchased 200,000 shares, representing 5.16% for ¥452.2 million. With this, the company has completed the repurchase of 200,000 shares, representing 5.16% for ¥452.2 million under the buyback announced on December 15, 2021.
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
J FRONTIER CO.,LTD. 
